Aya Jakobovits - Net Worth and Insider Trading

Aya Jakobovits Net Worth

The estimated net worth of Aya Jakobovits is at least $1 Million dollars as of 2024-04-27. Aya Jakobovits is the Director of Adicet Bio Inc and owns about 850,764 shares of Adicet Bio Inc (ACET) stock worth over $1 Million. Details can be seen in Aya Jakobovits's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Aya Jakobovits has not made any transactions after 2022-03-09 and currently still holds the listed stock(s).

Transaction Summary of Aya Jakobovits

To

Aya Jakobovits Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aya Jakobovits owns 1 companies in total, including Adicet Bio Inc (ACET) .

Click here to see the complete history of Aya Jakobovits’s form 4 insider trades.

Insider Ownership Summary of Aya Jakobovits

Ticker Comapny Transaction Date Type of Owner
ACET Adicet Bio Inc 2022-03-09 director

Aya Jakobovits Latest Holdings Summary

Aya Jakobovits currently owns a total of 1 stock. Aya Jakobovits owns 850,764 shares of Adicet Bio Inc (ACET) as of March 9, 2022, with a value of $1 Million.

Latest Holdings of Aya Jakobovits

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACET Adicet Bio Inc 2022-03-09 850,764 1.68 1,429,284

Holding Weightings of Aya Jakobovits


Aya Jakobovits Form 4 Trading Tracker

According to the SEC Form 4 filings, Aya Jakobovits has made a total of 5 transactions in Adicet Bio Inc (ACET) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Adicet Bio Inc is the sale of 4,000 shares on March 9, 2022, which brought Aya Jakobovits around $56,000.

Insider Trading History of Aya Jakobovits

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aya Jakobovits Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Aya Jakobovits Ownership Network

Ownership Network List of Aya Jakobovits

No Data

Ownership Network Relation of Aya Jakobovits


Aya Jakobovits Owned Company Details

What does Adicet Bio Inc do?

Who are the key executives at Adicet Bio Inc?

Aya Jakobovits is the director of Adicet Bio Inc. Other key executives at Adicet Bio Inc include director & 10 percent owner Orbimed Advisors Llc , director & See Remarks Chen Schor , and Chief Technology Officer Don Healey .

Adicet Bio Inc (ACET) Insider Trades Summary

Over the past 18 months, Aya Jakobovits made no insider transaction in Adicet Bio Inc (ACET). Other recent insider transactions involving Adicet Bio Inc (ACET) include a net sale of 95,268 shares made by Chen Schor , a net purchase of 4,000,000 shares made by Orbimed Advisors Llc , and a net purchase of 4,000,000 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Adicet Bio Inc (ACET) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 128,235 shares of Adicet Bio Inc (ACET) were sold and 8,016,000 shares were bought by its insiders, resulting in a net purchase of 7,887,765 shares.

Adicet Bio Inc (ACET)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adicet Bio Inc Insider Transactions

No Available Data

Aya Jakobovits Mailing Address

Above is the net worth, insider trading, and ownership report for Aya Jakobovits. You might contact Aya Jakobovits via mailing address: 3135 Hutton Drive, Beverly Hills Ca 90210.

Discussions on Aya Jakobovits

No discussions yet.